Vladimir Maletic, MD

Andrew Cutler, MD, shares his key takeaway advice to psychiatrists for the diagnosis and treatment of patients with bipolar 1 disorder.

Vladimir Maletic, MD, MS, and Andrew Cutler, MD, share their insights into considerations surrounding the use of long-acting injectables in bipolar 1 disorder.

Experts in psychiatry comment on the challenges of patient adherence to bipolar 1 disorder treatments and discuss the efficacy and safety of LAIs.

Vladimir Maletic, MD, MS, and Andrew Cutler, MD, highlight the use of long-acting injectables (LAIs) as a treatment option for bipolar 1 disorder.

Experts in psychiatry discuss the use of antipsychotics for treatment of bipolar 1 disorder.

Andrew Cutler, MD, reviews the different types of medications for the management of bipolar I disorder.

Vladimir Maletic, MD, MS, and Andrew Cutler, MD, review FDA approved medications for the treatment of bipolar I disorder.

Experts in psychiatry discuss common comorbidities associated with bipolar I disorder, highlighting substance use disorders and anxiety.

Drs Vladimir Maletic and Andrew Cutler explore symptoms associated with bipolar I disorder, such as sensory acuity, recurrent depression, and manic episodes.

Vladimir Maletic, MD, MS, and Andrew Cutler, MD, comment on the value of studying genetics and family history for diagnosing and treating bipolar 1 disorder.

Drs Vladimir Maletic and Andrew Cutler provide an overview of symptom differences between bipolar 1 disorder (B1D) and bipolar 2 disorder (B2D).

What the New Mind-Body Science Tells Us About the Pathophysiology of Major Depression-Focus on Treatment

As we begin this brief review of the neurobiology of major depressive disorder (MDD), we face these fundamental questions

We would suggest that psychiatry has spent so many years taking its diagnostic categories as God-given that it has become inured to the fact that these categories tell us very little about the etiology and fundamental nature of the conditions they purport to encompass.

Lecturing around the country has left us with the powerful impression that both psychiatrists and primary care physicians are hungry for new ways to think about and manage depression and the myriad symptoms and syndromes with which it is associated-including attention deficit disorder, insomnia, chronic pain conditions, substance abuse, and various states of disabling anxiety.

Lecturing around the country has left us with the powerful impression that both psychiatrists and primary care physicians are hungry for new ways to think about and treat depression and the myriad symptoms and syndromes with which it is associated-including attention deficit disorder, insomnia, chronic pain conditions, substance abuse, and various states of disabling anxiety. Primary care physicians also seem especially excited to learn that depression is not just a psychiatric illness but a behavioral manifestation of underlying pathophysiological processes that promote most of the other conditions they struggle to treat-including cardiovascular disease, diabetes, cancer, and dementia.1,2

Is sexual research still an orphan as far as recognition and funding? Yes. Yet sex and sexuality issues affect the quality of each person's life. As the articles in this Sex & Sexuality bonus issue show, sexual health remains in the physician's domain in this millennium and beyond.